drugset / Trial / NCT07246629

Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

NCT07246629

Phase 4 Not yet recruiting 214 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine the effectiveness of prophylactic administration of intra-thecal nicardipine though lumbar cerebrospinal fluid drain in prevention of symptomatic vasospasm in patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms.

Timeline

Start
2026-06
Primary completion
2027-01
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicardipine Small molecule 4 mg Intrathecal